Search

everythinglearnresearchcommunity

for

Search:↓

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Estrogen therapy can reduce skin aging but has cancer risks.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Menopause affects hair and skin; more research needed for treatment.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Hirsutism is too much hair growth in women like the pattern in men, often caused by high male hormones, and can be treated with hormone control and hair removal methods.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Spironolactone might cause painful intercourse and decreased sexual arousal in women.